Related Experiment Video
Updated: Nov 30, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Cellular reprogramming to model and study epigenetic alterations in cancer
1Department of Molecular and Medical Genetics, Cancer Early Detection Advanced Research Center, Knight Cancer Institute (Cancer Biology Research Program), Oregon Health & Science University School of Medicine, KCRB 5001.51, 2720 SW Moody Ave., Portland, OR 97201, United States.
Abstract:
Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer development. Master transcription factor-mediated cellular reprogramming of human cancer cells allows us to model cancer progression. Here I cover the history and recent advances in reprogramming cancer cells, followed by lessons from cellular reprogramming of normal cells that may apply to cancer. Lastly, I share my perspective on cellular reprogramming for studying epigenetic alterations that have occurred in tumorigenesis, discuss the current limitations, and propose ways to overcome the obstacles in the reprogramming of cancer.
Insights
Cancer progression involves non-genetic changes, like faulty gene regulation. Cellular reprogramming offers a way to study these epigenetic alterations in cancer, despite current limitations.
Area of Science:
- Epigenetics and Cancer Biology
- Cellular Reprogramming
Background:
- Cancer development requires genetic mutations but also relies on reversible non-genetic alterations.
- Dysregulation of gene expression through chromatin states and master transcription factors contributes to cancer etiology.
- Cellular reprogramming is a powerful tool for modeling cancer progression.
Purpose of the Study:
- To review the history and recent advances in reprogramming cancer cells.
- To explore lessons from normal cell reprogramming applicable to cancer research.
- To discuss the role of cellular reprogramming in studying epigenetic alterations in tumorigenesis.
Main Methods:
- Review of historical and recent literature on cancer cell reprogramming.
- Analysis of insights from normal cell reprogramming for cancer applications.
- Discussion of current limitations and future strategies for cancer cell reprogramming.
Main Results:
- Cellular reprogramming provides a model to study cancer progression driven by non-genetic factors.
- Understanding epigenetic alterations in cancer can be advanced through reprogramming techniques.
- Current reprogramming methods face limitations that need to be addressed for effective cancer research.
Conclusions:
- Cellular reprogramming is crucial for investigating the epigenetic basis of cancer.
- Overcoming obstacles in cancer cell reprogramming will enhance our understanding of tumorigenesis.
- Future research should focus on refining reprogramming strategies to study cancer's non-genetic drivers.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
07:53Application of RNAi and Heat-shock-induced Transcription Factor Expression to Reprogram Germ Cells to Neurons in C. elegans
Published on: January 1, 2018
Related Concept Videos
Somatic to iPS Cell Reprogramming
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Methods of Nuclear Reprogramming
Introduction to Nuclear Reprogramming
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...